Abstract
Biobanks are collections of biomaterials with associated data. Biobanking is an essential tool to provide access to high quality human biomaterial for fundamental and translational research. Research for rare disorders benefits from the provision of human biomaterials through biobanks, and each human sample from a person with a rare disorder has a high value as it may hold the key to answer an important research question. Transnational cooperation in biobanking is an important catalyst to share limited resources and achieve optimal outcomes as in other areas of rare disorder research. Networks of biobanks aim to assure common practices and quality standards, and facilitate access to rare disorder biomaterials for the scientific community.
This is a preview of subscription content, log in via an institution to check access.
References
Available from: http://www.telethon.it
Austin MA, Harding S, McElroy C (2003) Genebanks: a comparison of eight proposed international genetic databases. Community Genet 6(1):37–45
Editorial (2009) Biobanks need pharma. Nature 461(7263):448
Council Recommendation on a European action in the field of rare diseases. 2008
Hens K, Nys H, Cassiman JJ, Dierickx K (2009) Biological sample collections from minors for genetic research: a systematic review of guidelines and position papers. Eur J Hum Genet 17(8):979–990
Jaksch M, Paret C, Stucka R, Horn N, Müller-Höcker J, Horvath R, Trepesch N, Stecker G, Freisinger P, Thirion C, Müller J, Lunkwitz R, Rödel G, Shoubridge EA, Lochmüller H (2001) Cytochrome c oxidase deficiency due to mutations in SCO2, encoding a mitochondrial copper-binding protein, is rescued by copper in human myoblasts. Hum Mol Genet 10(26):3025–3035
Janiesch PC, Kim J, Mouysset J, Barikbin R, Lochmüller H, Cassata G, Krause S, Hoppe T (2007) The ubiquitin-selective chaperone CDC-48/p97 links myosin assembly to human myopathy. Nat Cell Biol 9(4):379–390
Lacroix M (2008) Persistent use of “false” cell lines. Int J Cancer 122(1):1–4
Martin Uranga A, Martín Arribas MC, Jaeger C, Posada M (2005) Outstanding ethical-legal issues on biobanks. An overview on the regulations of the Member States of the Eurobiobank project. Law Hum Genome Rev (22):103–114
Mayrhofer MT, Prainsack B (2009) Being a member of the club: the transnational (self-) governance of networks of biobanks. Int J Risk Assessment Manag 12(1):64
OECD, Guidance for the Operation of Biological Research Centres (BRCs). 2004. Available at http://www.oecd.org/dataoecd/60/44/23547773.pdf
OECD (2006) Glossary of Statistical Terms. Available at http://stats.oecd.org/glossary/detail.asp?ID=7220
OECD (2007) Best Practice Guidelines for Biological Resource Centres. Available at http://www.oecd.org/dataoecd/6/27/38778261.pdf
Rare Diseases: Understanding this Public Health Priority. 2005, Eurordis: Paris
Schroers A, Kley RA, Stachon A, Horvath R, Lochmüller H, Zange J, Vorgerd M (2006) Gentamicin treatment in McArdle disease: failure to correct myophosphorylase deficiency. Neurology 66(2):285–296
Acknowledgements
We thank Dr. Fabrizia Bignami (Eurordis, Paris, France) for critically reviewing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Netherlands
About this chapter
Cite this chapter
Lochmüller, H., Schneiderat, P. (2010). Biobanking in Rare Disorders. In: Posada de la Paz, M., Groft, S. (eds) Rare Diseases Epidemiology. Advances in Experimental Medicine and Biology, vol 686. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9485-8_7
Download citation
DOI: https://doi.org/10.1007/978-90-481-9485-8_7
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9484-1
Online ISBN: 978-90-481-9485-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)